Concepts (260)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hemostatics | 2 | 2017 | 142 | 0.59 | Why? |
| Counseling | 1 | 2021 | 747 | 0.56 | Why? |
| Mentoring | 1 | 2021 | 432 | 0.56 | Why? |
| Blood Safety | 3 | 2021 | 459 | 0.54 | Why? |
| Chikungunya virus | 1 | 2017 | 339 | 0.54 | Why? |
| Fibrinogen | 2 | 2017 | 1048 | 0.52 | Why? |
| Chikungunya Fever | 1 | 2017 | 345 | 0.50 | Why? |
| Sexual Behavior | 1 | 2021 | 1322 | 0.45 | Why? |
| Blood Donors | 6 | 2021 | 2956 | 0.43 | Why? |
| Blood Transfusion | 6 | 2020 | 1399 | 0.33 | Why? |
| Hemorrhage | 6 | 2018 | 3013 | 0.32 | Why? |
| Tranexamic Acid | 2 | 2018 | 121 | 0.32 | Why? |
| Arteriovenous Malformations | 2 | 2019 | 33 | 0.32 | Why? |
| Blood Loss, Surgical | 2 | 2018 | 211 | 0.31 | Why? |
| Platelet Transfusion | 2 | 2018 | 209 | 0.31 | Why? |
| Fear | 1 | 2021 | 3607 | 0.29 | Why? |
| Internet | 1 | 2021 | 6204 | 0.24 | Why? |
| Hemophilia A | 2 | 2017 | 362 | 0.23 | Why? |
| Sexuality | 1 | 2021 | 85 | 0.21 | Why? |
| ABO Blood-Group System | 2 | 2021 | 995 | 0.20 | Why? |
| Hydrocarbons, Chlorinated | 1 | 2019 | 11 | 0.20 | Why? |
| Polychlorinated Biphenyls | 1 | 2019 | 14 | 0.20 | Why? |
| Arteriovenous Fistula | 1 | 2019 | 23 | 0.20 | Why? |
| Tissue Expansion Devices | 1 | 2018 | 21 | 0.19 | Why? |
| Tennis Elbow | 1 | 2018 | 6 | 0.19 | Why? |
| Bipolar Disorder | 2 | 2018 | 744 | 0.19 | Why? |
| Fasciitis, Plantar | 1 | 2018 | 8 | 0.19 | Why? |
| Breast Implantation | 1 | 2018 | 23 | 0.19 | Why? |
| Antipsychotic Agents | 2 | 2018 | 887 | 0.19 | Why? |
| Risperidone | 1 | 2018 | 55 | 0.19 | Why? |
| Cytoskeleton | 1 | 2019 | 99 | 0.19 | Why? |
| Blood Preservation | 2 | 2017 | 191 | 0.19 | Why? |
| Factor VIII | 2 | 2017 | 229 | 0.19 | Why? |
| Aripiprazole | 1 | 2018 | 60 | 0.18 | Why? |
| Pesticides | 1 | 2019 | 100 | 0.18 | Why? |
| Platelet-Rich Plasma | 1 | 2018 | 91 | 0.17 | Why? |
| Pulmonary Veins | 1 | 2019 | 146 | 0.17 | Why? |
| Dairying | 1 | 2017 | 46 | 0.17 | Why? |
| Food Contamination | 1 | 2019 | 142 | 0.17 | Why? |
| Crime Victims | 1 | 2020 | 148 | 0.17 | Why? |
| Food Safety | 1 | 2019 | 145 | 0.17 | Why? |
| Antisepsis | 1 | 2017 | 30 | 0.17 | Why? |
| Radiography, Interventional | 1 | 2019 | 158 | 0.17 | Why? |
| Gels | 1 | 2017 | 111 | 0.17 | Why? |
| Stomatitis | 1 | 2017 | 57 | 0.17 | Why? |
| Cell Count | 1 | 2017 | 228 | 0.17 | Why? |
| Donor Selection | 2 | 2021 | 804 | 0.17 | Why? |
| Dabigatran | 1 | 2019 | 204 | 0.16 | Why? |
| Day Care, Medical | 1 | 2018 | 117 | 0.16 | Why? |
| Soft Tissue Neoplasms | 1 | 2018 | 131 | 0.16 | Why? |
| Fetal Blood | 2 | 2017 | 573 | 0.16 | Why? |
| Blood Platelets | 2 | 2018 | 1704 | 0.16 | Why? |
| Milk | 1 | 2017 | 158 | 0.16 | Why? |
| West Nile virus | 1 | 2017 | 206 | 0.15 | Why? |
| West Nile Fever | 1 | 2017 | 166 | 0.15 | Why? |
| Myocytes, Cardiac | 2 | 2019 | 804 | 0.15 | Why? |
| Antithrombins | 1 | 2019 | 353 | 0.15 | Why? |
| Masticatory Muscles | 1 | 2014 | 5 | 0.15 | Why? |
| Blood Banks | 2 | 2021 | 535 | 0.14 | Why? |
| Sarcoma | 1 | 2018 | 290 | 0.14 | Why? |
| Mammaplasty | 1 | 2018 | 224 | 0.14 | Why? |
| Piperazines | 1 | 2018 | 445 | 0.14 | Why? |
| Hepatitis E virus | 1 | 2018 | 306 | 0.14 | Why? |
| Intimate Partner Violence | 1 | 2020 | 363 | 0.14 | Why? |
| Ventricular Remodeling | 1 | 2018 | 349 | 0.14 | Why? |
| Mouth Mucosa | 1 | 2017 | 323 | 0.13 | Why? |
| Carbamates | 1 | 2018 | 485 | 0.13 | Why? |
| Environmental Pollutants | 1 | 2019 | 320 | 0.13 | Why? |
| Regeneration | 1 | 2017 | 429 | 0.13 | Why? |
| Mastectomy | 1 | 2018 | 536 | 0.13 | Why? |
| Hepatitis E | 1 | 2018 | 319 | 0.13 | Why? |
| Fibroblasts | 1 | 2018 | 839 | 0.13 | Why? |
| Weight Gain | 1 | 2018 | 552 | 0.13 | Why? |
| Blood Specimen Collection | 1 | 2017 | 387 | 0.13 | Why? |
| Erythrocyte Transfusion | 1 | 2017 | 386 | 0.13 | Why? |
| Cryopreservation | 1 | 2017 | 464 | 0.13 | Why? |
| Temporomandibular Joint Disorders | 1 | 2014 | 77 | 0.12 | Why? |
| Domestic Violence | 1 | 2020 | 522 | 0.12 | Why? |
| Aorta | 1 | 2016 | 355 | 0.12 | Why? |
| Adipose Tissue | 1 | 2018 | 612 | 0.12 | Why? |
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2013 | 51 | 0.12 | Why? |
| Electromyography | 1 | 2014 | 278 | 0.12 | Why? |
| One Health | 1 | 2017 | 390 | 0.12 | Why? |
| Benzodiazepines | 1 | 2014 | 163 | 0.12 | Why? |
| Thrombelastography | 1 | 2018 | 627 | 0.12 | Why? |
| Pulmonary Artery | 1 | 2019 | 803 | 0.12 | Why? |
| Polysomnography | 1 | 2014 | 296 | 0.12 | Why? |
| Italy | 11 | 2021 | 38444 | 0.12 | Why? |
| Mitochondria | 1 | 2019 | 857 | 0.11 | Why? |
| Humidity | 1 | 2017 | 944 | 0.11 | Why? |
| Anemia | 1 | 2017 | 789 | 0.10 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.10 | Why? |
| Orthopedic Procedures | 2 | 2018 | 1231 | 0.10 | Why? |
| Humans | 49 | 2021 | 930598 | 0.10 | Why? |
| Hepacivirus | 1 | 2018 | 1509 | 0.09 | Why? |
| Thromboembolism | 2 | 2020 | 2101 | 0.09 | Why? |
| Patient Education as Topic | 1 | 2018 | 1476 | 0.09 | Why? |
| Cost-Benefit Analysis | 1 | 2017 | 2259 | 0.09 | Why? |
| Female | 30 | 2021 | 380317 | 0.09 | Why? |
| Cesarean Section | 1 | 2018 | 2089 | 0.08 | Why? |
| Temperature | 1 | 2017 | 2305 | 0.08 | Why? |
| Nomograms | 1 | 2013 | 790 | 0.08 | Why? |
| Blood Coagulation Disorders | 1 | 2020 | 2040 | 0.08 | Why? |
| Hepatitis C | 1 | 2018 | 1514 | 0.08 | Why? |
| Environmental Monitoring | 1 | 2019 | 3143 | 0.08 | Why? |
| Liver Cirrhosis | 2 | 2018 | 1810 | 0.08 | Why? |
| Male | 24 | 2021 | 367725 | 0.07 | Why? |
| Disinfection | 1 | 2018 | 2912 | 0.07 | Why? |
| Kidney | 1 | 2019 | 3648 | 0.07 | Why? |
| Atrial Fibrillation | 1 | 2019 | 2320 | 0.07 | Why? |
| Wounds and Injuries | 1 | 2017 | 1708 | 0.07 | Why? |
| Hepatitis C, Chronic | 1 | 2013 | 973 | 0.07 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2018 | 3388 | 0.07 | Why? |
| Guideline Adherence | 1 | 2017 | 2309 | 0.07 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 2426 | 0.06 | Why? |
| HIV-1 | 1 | 2018 | 3365 | 0.06 | Why? |
| Postoperative Complications | 2 | 2018 | 5861 | 0.06 | Why? |
| Specimen Handling | 1 | 2021 | 6190 | 0.06 | Why? |
| Costs and Cost Analysis | 2 | 2018 | 694 | 0.06 | Why? |
| Heart Diseases | 1 | 2020 | 3503 | 0.06 | Why? |
| Disease Outbreaks | 3 | 2021 | 27595 | 0.06 | Why? |
| Inflammation | 3 | 2020 | 13255 | 0.06 | Why? |
| Sleep Initiation and Maintenance Disorders | 1 | 2014 | 1692 | 0.06 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.06 | Why? |
| Population Surveillance | 1 | 2017 | 4967 | 0.05 | Why? |
| Breast Neoplasms | 1 | 2018 | 3633 | 0.05 | Why? |
| Epidemics | 1 | 2021 | 6407 | 0.05 | Why? |
| Anticoagulants | 2 | 2020 | 9563 | 0.05 | Why? |
| Aggression | 1 | 2020 | 126 | 0.05 | Why? |
| Substance-Related Disorders | 1 | 2014 | 2038 | 0.05 | Why? |
| Venous Thromboembolism | 1 | 2018 | 4273 | 0.05 | Why? |
| Food Analysis | 1 | 2019 | 53 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 4 | 2018 | 10649 | 0.05 | Why? |
| Fishes | 1 | 2019 | 99 | 0.05 | Why? |
| Thrombosis | 2 | 2020 | 7504 | 0.05 | Why? |
| Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.04 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.04 | Why? |
| Osteosarcoma | 1 | 2018 | 83 | 0.04 | Why? |
| Aged | 12 | 2021 | 215776 | 0.04 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.04 | Why? |
| Hepatitis Antibodies | 1 | 2018 | 100 | 0.04 | Why? |
| Cytarabine | 1 | 2017 | 64 | 0.04 | Why? |
| Mental Health | 2 | 2021 | 15770 | 0.04 | Why? |
| Magnetic Resonance Imaging | 1 | 2014 | 6551 | 0.04 | Why? |
| Adolescent | 8 | 2021 | 86841 | 0.04 | Why? |
| Trauma Severity Indices | 1 | 2017 | 176 | 0.04 | Why? |
| Transplantation, Autologous | 1 | 2018 | 364 | 0.04 | Why? |
| Plasmapheresis | 1 | 2020 | 437 | 0.04 | Why? |
| Mental Disorders | 1 | 2020 | 6742 | 0.04 | Why? |
| Benchmarking | 1 | 2021 | 627 | 0.04 | Why? |
| Atmosphere | 1 | 2017 | 103 | 0.04 | Why? |
| Adult | 13 | 2021 | 244371 | 0.04 | Why? |
| Kidney Function Tests | 1 | 2019 | 520 | 0.04 | Why? |
| Cytokines | 1 | 2019 | 15010 | 0.04 | Why? |
| Stress, Psychological | 1 | 2020 | 10231 | 0.04 | Why? |
| Human Umbilical Vein Endothelial Cells | 1 | 2018 | 286 | 0.04 | Why? |
| PubMed | 1 | 2018 | 246 | 0.04 | Why? |
| Epithelium | 1 | 2018 | 330 | 0.04 | Why? |
| Prevalence | 4 | 2021 | 25773 | 0.04 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.04 | Why? |
| Neoplasm Metastasis | 1 | 2018 | 682 | 0.04 | Why? |
| Bone Neoplasms | 1 | 2018 | 287 | 0.04 | Why? |
| Immunization, Passive | 2 | 2021 | 10067 | 0.03 | Why? |
| Endothelium | 1 | 2018 | 460 | 0.03 | Why? |
| Fibrosis | 1 | 2018 | 800 | 0.03 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.03 | Why? |
| Administration, Intravenous | 1 | 2018 | 1115 | 0.03 | Why? |
| RNA, Viral | 2 | 2018 | 32276 | 0.03 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Clinical Trials, Phase III as Topic | 1 | 2017 | 782 | 0.03 | Why? |
| Cattle | 1 | 2017 | 1336 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2019 | 1136 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.03 | Why? |
| Activities of Daily Living | 1 | 2021 | 1530 | 0.03 | Why? |
| Body Weight | 1 | 2018 | 1074 | 0.03 | Why? |
| Child | 5 | 2021 | 70012 | 0.03 | Why? |
| Blood Component Transfusion | 1 | 2017 | 740 | 0.03 | Why? |
| Rome | 1 | 2014 | 497 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2017 | 1654 | 0.03 | Why? |
| Immunoglobulin M | 2 | 2021 | 9091 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2021 | 253789 | 0.03 | Why? |
| Blood Coagulation Tests | 1 | 2017 | 855 | 0.03 | Why? |
| Psychiatric Status Rating Scales | 1 | 2018 | 1340 | 0.03 | Why? |
| Feasibility Studies | 1 | 2020 | 3467 | 0.03 | Why? |
| Neoplasm Recurrence, Local | 1 | 2018 | 1063 | 0.03 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.03 | Why? |
| Cytomegalovirus Infections | 1 | 2017 | 667 | 0.03 | Why? |
| Platelet Count | 1 | 2017 | 1381 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Enoxaparin | 1 | 2017 | 1064 | 0.03 | Why? |
| Regression Analysis | 1 | 2017 | 2484 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2019 | 17020 | 0.02 | Why? |
| Odds Ratio | 1 | 2021 | 5861 | 0.02 | Why? |
| Interferon-gamma | 1 | 2019 | 2711 | 0.02 | Why? |
| Pilot Projects | 1 | 2020 | 5182 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2019 | 2483 | 0.02 | Why? |
| Animals | 4 | 2019 | 78931 | 0.02 | Why? |
| Life Style | 1 | 2021 | 2708 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2019 | 5814 | 0.02 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.02 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2017 | 1731 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Prospective Studies | 3 | 2019 | 43301 | 0.02 | Why? |
| Cells, Cultured | 1 | 2019 | 5835 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Apoptosis | 1 | 2018 | 2335 | 0.02 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2017 | 1261 | 0.02 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2018 | 5542 | 0.02 | Why? |
| Orthopedics | 1 | 2018 | 1279 | 0.02 | Why? |
| Electroencephalography | 1 | 2014 | 1242 | 0.02 | Why? |
| Psychometrics | 1 | 2014 | 1269 | 0.02 | Why? |
| Forecasting | 1 | 2021 | 4492 | 0.02 | Why? |
| Myocardium | 1 | 2018 | 2323 | 0.02 | Why? |
| Autoantibodies | 1 | 2017 | 2094 | 0.02 | Why? |
| Outpatients | 1 | 2018 | 3417 | 0.02 | Why? |
| Body Mass Index | 1 | 2018 | 4306 | 0.02 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2018 | 4020 | 0.02 | Why? |
| Immunoglobulins, Intravenous | 1 | 2017 | 2705 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
| Biopsy | 1 | 2013 | 2811 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2019 | 7220 | 0.02 | Why? |
| Heart Rate | 1 | 2014 | 1527 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| France | 1 | 2020 | 12074 | 0.02 | Why? |
| Infant | 2 | 2018 | 30274 | 0.02 | Why? |
| Survival Rate | 1 | 2017 | 9206 | 0.02 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Child, Preschool | 2 | 2018 | 36283 | 0.01 | Why? |
| Treatment Outcome | 2 | 2018 | 51732 | 0.01 | Why? |
| Interleukin-6 | 1 | 2019 | 7522 | 0.01 | Why? |
| Mass Screening | 1 | 2021 | 8005 | 0.01 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.01 | Why? |
| Quality of Life | 1 | 2021 | 9820 | 0.01 | Why? |
| Sepsis | 1 | 2017 | 3517 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.01 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.01 | Why? |
| Liver | 1 | 2013 | 4007 | 0.01 | Why? |
| Chronic Disease | 1 | 2014 | 5139 | 0.01 | Why? |
| Disease Management | 1 | 2017 | 6841 | 0.01 | Why? |
| Risk Factors | 2 | 2018 | 71621 | 0.01 | Why? |
| Immunosuppressive Agents | 1 | 2017 | 6331 | 0.01 | Why? |
| Registries | 1 | 2018 | 12327 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2013 | 9537 | 0.01 | Why? |
| Pulmonary Embolism | 1 | 2017 | 4775 | 0.01 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.01 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.01 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.01 | Why? |
| Time Factors | 1 | 2018 | 31397 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2017 | 9044 | 0.01 | Why? |
| Depression | 1 | 2018 | 14116 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2013 | 22971 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.01 | Why? |
| HIV Infections | 1 | 2018 | 11620 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.01 | Why? |
| Neoplasms | 1 | 2019 | 17251 | 0.01 | Why? |
| Prognosis | 1 | 2013 | 32490 | 0.01 | Why? |
| Hospitalization | 1 | 2017 | 54280 | 0.00 | Why? |